We have tracked, categorized under Education, Health, over 0 funding programs and $0 allocated funding to date.

Recent published funding opportunities:

Funding Opportunity
Limited Competition: AIDS Malignancy Consortium (AMC; UM1 Clinical Trial Required) Apply for RFA CA 24 028

Funding Number: RFA CA 24 028
Agency: National Institutes of Health
Funding Amount: Case Dependent
HEAL Initiative: HEAL Data2Action Innovation and Acceleration Projects, Phased Awards (R61/R33, Clinical Trial Optional) Apply for RFA DA 23 057

Funding Number: RFA DA 23 057
Agency: National Institutes of Health
Funding Amount: $750,000
NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional) Apply for RFA CA 22 050

Funding Number: RFA CA 22 050
Agency: National Institutes of Health
Funding Amount: Case Dependent
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 22 002

Funding Number: RFA CA 22 002
Agency: National Institutes of Health
Funding Amount: $300,000
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed) Apply for PAR 21 277

Funding Number: PAR 21 277
Agency: National Institutes of Health
Funding Amount: Case Dependent
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) Apply for PAR 21 033

Funding Number: PAR 21 033
Agency: National Institutes of Health
Funding Amount: Case Dependent
Exploring the Roles of Biomolecular Condensates (BMCs) in HIV replication, latency, or pathogenesis in the context of substance use disorders (R21/R33 Clinical Trial Not Allowed) Apply for RFA DA 21 004

Funding Number: RFA DA 21 004
Agency: National Institutes of Health
Funding Amount: Case Dependent
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) Apply for PAR 18 892

Funding Number: PAR 18 892
Agency: National Institutes of Health
Funding Amount: $200,000
Addressing Chronic Wound Trajectories Through Social Genomics Research (R21 Clinical Trial Optional) Apply for PA 17 493

Funding Number: PA 17 493
Agency: National Institutes of Health
Funding Amount: $200,000
Expanding Medication Assisted Treatment for Opioid Use Disorders in the Context of the SAMHSA Opioid STR Grants (R21/R33) Apply for RFA DA 18 005

Funding Number: RFA DA 18 005
Agency: National Institutes of Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More